Comments
Dr Reddy’s Laboratories Ltd today announced the commercialsation of Vozet tablets in India. It is indicated for the treatment of allergic Rhinitis and chronic Urticaria.
Vozet tablets contain Levocetirizine 5 mg, and are available in a strip size of 10.
The anti-histamine market in India had sales of Rs 1,038 crore for the most recent 12 months ended March 31, 2017, according to IMS ORG.
Dr Reddy’s will further strengthen its anti-allergy portfolio with the addition of Vozet, a company release stated.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.